V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009285 | 260012208 | 1.67 | 83.1 | Disease modification (D) | 2013-11-23 | 2013-11-23 | Cisplatin + Etoposide (3 day) | N | N | 260029566 | CARBOPLATIN + ETOPOSIDE |
| 260009286 | 260012208 | 1.59 | 77 | Curative (C) | 2018-01-19 | 2018-01-22 | Rituximab | N | N | 260029566 | CHOP |
| 260009287 | 260006039 | null | 78.8 | Curative (C) | 2015-03-22 | 2015-04-20 | CHOP - 21 days | 02 | N | 260029570 | CARBOPLATIN + ETOPOSIDE |
| 260009288 | 260012209 | 1.66 | 52.1 | Curative (C) | 2017-01-04 | 2017-01-11 | Doxorubicin + Olaratumab | N | N | 260029571 | BEAM |
| 260009289 | 260006040 | null | null | Not known (9) | 2018-02-22 | 2018-02-22 | Cisplatin + Etoposide (5 day) | null | N | 260029572 | CISPLATIN + ETOPOSIDE |
| 260009290 | 260006041 | 0 | 69.2 | Curative (C) | 2017-10-15 | 2017-10-22 | Chlorambucil | 01 | N | 260029578 | RITUXIMAB |
| 260009291 | 260012210 | 1.68 | 69 | null | 2014-10-08 | 2014-11-26 | Chlorambucil | N | N | 260029579 | RITUXIMAB |
| 260009292 | 260006042 | 1.76 | 65.7 | Adjuvant (A) | 2017-03-08 | 2017-03-19 | Rituximab | N | Y | 260029580 | RITUXIMAB |
| 260009293 | 260006043 | 1.59 | 84 | Palliative (P) | 2016-08-14 | 2016-08-21 | BENDAMUSTINE | 2 | N | 260029582 | RITUXIMAB |
| 260009294 | 260006044 | 1.52 | 58 | Disease modification (D) | 2018-03-13 | 2018-03-20 | Rituximab | 02 | N | 260029583 | RITUXIMAB |
| 260009295 | 260012211 | 1.81 | null | Curative (C) | 2016-12-06 | 2016-12-09 | Rituximab (SUBCUTANEOUS Maintenance) | 99 | N | 260029587 | RITUXIMAB |
| 260009296 | 260006045 | 1.73 | 137 | Disease modification (D) | 2017-04-14 | 2017-04-26 | Rituximab (Maintenance) | N | N | 260029590 | GALLIUM TRIAL |
| 260009297 | 260006045 | 1.55 | 68 | null | 2015-04-24 | 2015-04-24 | Rituximab | N | N | 260029590 | RITUXIMAB |
| 260009298 | 260006046 | 1.52 | 0 | Disease modification (D) | 2018-10-14 | 2018-10-14 | Rituximab | N | N | 260029592 | BENDAMUSTINE |
| 260009299 | 260006046 | 1.56 | 94.3 | Palliative (P) | 2013-02-23 | 2013-03-23 | Rituximab | 02 | N | 260029592 | DHAP |
| 260009300 | 260006047 | 1.84 | 134 | Curative (C) | 2015-08-17 | 2015-08-25 | Rituximab | N | N | 260029594 | ABVD |
| 260009301 | 260006047 | 1.7 | 89.9 | Adjuvant (A) | 2015-12-27 | 2016-01-19 | CISPLATIN + ETOPOSIDE | 2 | Y | 260029594 | CISPLATIN + VINORELBINE |
| 260009302 | 260006047 | 1.73 | 68.5 | null | null | 2015-02-20 | RCEOP | null | null | 260029594 | CYCLOPHOSPHAMIDE |
| 260009303 | 260006048 | null | 76.4 | Curative (C) | 2017-02-18 | 2017-02-24 | Cisplatin + Etoposide (3 day) | Y | N | 260029603 | EP |
| 260009304 | 260006048 | null | 81 | Curative (C) | 2015-11-11 | 2015-11-11 | Rituximab | null | Y | 260029603 | NOT MATCHED |
| 260009305 | 260006048 | 1.67 | 90 | Curative (C) | 2018-07-29 | 2018-08-12 | Rituximab (Maintenance) | 02 | N | 260029603 | RITUXIMAB |
| 260009306 | 260006048 | 1.67 | 73 | Palliative (P) | 2014-03-06 | 2014-03-07 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260029603 | RITUXIMAB |
| 260009307 | 260006049 | 1.56 | 166 | Palliative (P) | 2014-09-08 | 2014-09-22 | CHOP - 21 days | N | N | 260029611 | HYDROXYCARBAMIDE |
| 260009308 | 260006049 | null | 73 | null | 2014-12-04 | 2014-12-05 | Rituximab | N | N | 260029611 | CHOP |
| 260009309 | 260006049 | null | 106.4 | Palliative (P) | 2016-11-05 | 2016-11-06 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 260029611 | FCR |
| 260009312 | 260006051 | 1.57 | 68.3 | Not known (9) | 2017-09-26 | 2017-10-03 | Rituximab | 02 | null | 260029620 | RITUXIMAB |
| 260009313 | 260012218 | 1.75 | 101 | Curative (C) | 2017-10-05 | 2017-10-06 | Rituximab | 02 | N | 260029622 | RITUXIMAB |
| 260009314 | 260012218 | 1.74 | 69.6 | Neo-adjuvant (N) | 2015-11-20 | 2016-07-08 | Cisplatin + Radiotherapy | N | N | 260029622 | RITUXIMAB |
| 260009315 | 260012218 | 0 | 62 | Palliative (P) | 2017-05-06 | 2017-05-13 | R-CHOEP | 2 | Y | 260029622 | RITUXIMAB |
| 260009316 | 260006052 | 1.61 | 88.1 | Curative (C) | 2013-05-29 | 2013-06-17 | ESHAP R | 02 | N | 260029628 | RITUXIMAB |
| 260009317 | 260012219 | 1.7 | null | Adjuvant (A) | 2017-07-07 | 2017-07-13 | Rituximab | N | N | 260029630 | CARBOPLATIN + PACLITAXEL |
| 260009318 | 260012219 | 1.58 | 108 | Curative (C) | 2015-10-07 | 2015-10-17 | BENDAMUSTINE | N | Y | 260029630 | ABVD R |
| 260009319 | 260012219 | null | 94 | Palliative (P) | 2017-01-09 | 2017-01-17 | Rituximab | N | N | 260029630 | RITUXIMAB |
| 260009320 | 260006053 | 1.77 | 117 | Curative (C) | 2014-04-19 | 2014-05-06 | RCEOP | N | N | 260029641 | PACIFICO TRIAL |
| 260009321 | 260006053 | null | 90 | null | null | 2014-01-04 | CYCLO + RITUXIMAB + VINCRISTINE | null | null | 260029641 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260009322 | 260006054 | 1.68 | 94.7 | Palliative (P) | 2013-09-30 | 2014-03-30 | Rituximab | N | N | 260029644 | RCEOP |
| 260009323 | 260006054 | 1.65 | 165 | Disease modification (D) | 2014-09-14 | 2014-09-14 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 260029644 | DHAP - R |
| 260009324 | 260006054 | 1.83 | 84 | Curative (C) | 2013-04-08 | 2013-04-20 | Capecitabine 35days + RT | 02 | N | 260029644 | CHLORAMBUCIL + RITUXIMAB |
| 260009325 | 260006055 | 1.61 | 56.6 | Palliative (P) | 2018-12-18 | 2018-12-18 | Rituximab | N | N | 260029649 | RITUXIMAB |
| 260009326 | 260006055 | 1.91 | 119.4 | Palliative (P) | 2014-10-26 | 2014-11-09 | PACIFICO TRIAL | N | N | 260029649 | RITUXIMAB |
| 260009327 | 260006056 | 1.81 | 114 | Curative (C) | 2017-03-08 | 2017-03-08 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | N | N | 260029653 | RITUXIMAB |
| 260009328 | 260006056 | 1.64 | null | Palliative (P) | 2013-12-21 | 2014-01-03 | Rituximab | N | N | 260029653 | RITUXIMAB |
| 260009329 | 260006056 | null | 59 | Palliative (P) | 2015-10-28 | 2015-10-28 | Rituximab | 02 | N | 260029653 | RCEOP |
| 260009330 | 260006057 | 1.75 | 72.3 | Curative (C) | 2017-10-08 | 2017-10-13 | CVP | N | N | 260029659 | VINCRISTINE |
| 260009331 | 260006057 | 1.66 | null | Curative (C) | 2016-02-29 | 2016-02-29 | Rituximab | N | N | 260029659 | RITUXIMAB |
| 260009332 | 260006058 | 1.5 | 82 | Curative (C) | 2016-09-07 | 2016-09-11 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | 260029663 | RITUXIMAB |
| 260009333 | 260012225 | 1.66 | 82 | Curative (C) | 2015-07-26 | 2015-07-30 | CHOP - 21 days | 02 | N | 260029664 | RITUXIMAB |
| 260009334 | 260006059 | 1.69 | null | Palliative (P) | 2018-05-09 | 2018-05-10 | RCEOP | 02 | N | 260029666 | RITUXIMAB |
| 260009335 | 260006059 | 1.74 | 92.2 | Adjuvant (A) | 2016-08-14 | 2016-08-25 | Rituximab | 2 | N | 260029666 | RITUXIMAB |
| 260009336 | 260006060 | null | null | Disease modification (D) | 2017-07-27 | 2017-07-29 | ESHAP | N | N | 260029668 | CAPECITABINE |